| Literature DB >> 29695926 |
Ubedullah Kaka1,2, Nor-Alimah Rahman1, Adamu Abdul Abubakar1,3, Yong Meng Goh2,4, Sharida Fakurazi5,6, Mohamed Ariff Omar4, Hui Cheng Chen1.
Abstract
OBJECTIVES: The effects of pre-emptive infusion of ketamine-lidocaine with tramadol on the suppression of central sensitization were investigated in a dog ovariohysterectomy model. PATIENTS AND METHODS: Twelve dogs were randomly assigned to two groups: ketamine-lidocaine-tramadol (KLT) and tramadol (T) groups. Both groups received intravenous tramadol 4 mg/kg body weight as premedication. Immediately after induction, the KLT group received ketamine and lidocaine at 0.5 and 2 mg/kg loading dose, followed by continuous rate infusion of 50 and 100 µg/kg/min, respectively, for 2 hours. Dogs in T group received saline bolus and continuous rate infusion at equi-volume. Intraoperatively, hemodynamic responses to surgical stimulation were recorded, whereas postoperative pain was evaluated using an algometer and short form of the Glasgow composite measure pain scale.Entities:
Keywords: central sensitization; ketamine; lidocaine; postoperative pain; pre-emptive multimodal analgesia; tramadol
Year: 2018 PMID: 29695926 PMCID: PMC5905489 DOI: 10.2147/JPR.S152475
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Mean body weight, total surgery time, total anesthesia time, time to extubation, end tidal Iso at the time of extubation, sternal recumbency, and standing of dogs with KLT combination and T alone
| Parameter | KLT | T | |
|---|---|---|---|
| Body weight (kg) | 16.40±2.20 | 14.40±3.20 | 0.24 |
| Total surgery time (min) | 37.0±7.50 | 33.0±5.20 | 0.39 |
| Total anesthesia time (min) | 88.0±19.20 | 75.0±6.60 | 0.16 |
| Time from cessation of isoflurane to extubation (min) | 24.0±12.70 | 10.0±6.20 | 0.03 |
| ETIso at the time of extubation (%) | 0.27±0.03 | 0.52±0.20 | 0.02 |
| Time from extubation to sternal recumbency (min) | 24.0±12.50 | 13.0±11.90 | 0.13 |
| Time from extubation to standing (min) | 61.0±24.60 | 30.0±18.10 | 0.03 |
Note: Data presented as mean ± SD.
Abbreviations: ETIso, end-tidal isoflurane concentration; KLT, ketamine, lidocaine, and tramadol; T, tramadol.
Median values (range) for ETiso concentration, respiration rate, and ETCO2 during surgical manipulations in both KLT and T groups
| Event during surgery | ETiso concentration (%)
| Respiration rate (breaths/min)
| ETCO2 concentration (%)
| |||
|---|---|---|---|---|---|---|
| KLT | T | KLT | T | KLT | T | |
| Skin prep (baseline) | 1.3 (1.1–1.5) | 1.4 (1.4–1.6) | 9 (5–12) | 16 (9–20) | 52 (44–57) | 43 (29–46) |
| Skin incision | 1.4 (1.3–1.5) | 1.4 (1.4–1.6) | 7 (5–13) | 17 (16–19) | 57 (48–64) | 40 (22–48) |
| First pedicle | 1.4 (1.3–1.5) | 1.4 (1.2–1.5) | 11 (6–18) | 17 (16–25) | 56 (49–66) | 37 (32–45) |
| Second pedicle | 1.4 (1.4–1.5) | 1.4 (1.2–1.8) | 10 (6–17) | 16 (15–20) | 57 (49–76) | 40 (32–45) |
| Uterine body | 1.4 (1.4–1.5) | 1.4 (1.2–2.0) | 10 (4–17) | 18 (16–30) | 58 (54–73) | 40 (35–45) |
| Linea alba | 1.4 (1.4–2.0) | 1.4 (1.2–2.2) | 8 (4–10) | 16 (16–19) | 56 (52–84) | 38 (33–45) |
| Subcutaneous | 1.4 (1.4–1.7) | 1.3 (1.2–2.3) | 8 (6–11) | 17 (14–22) | 55 (37–60) | 38 (30–43) |
| Skin closure | 1.4 (1.4–1.7) | 1.4 (1.3–2.2) | 9 (6–11) | 18 (15–21) | 55 (37–60) | 38 (30–43) |
Notes:
Significantly different from KLT at corresponding time points (Mann–Whitney U test P<0.05).
Abbreviations: KLT, ketamine, lidocaine, and tramadol; T, tramadol.
Median values (range) for intraoperative heart rate, mean blood pressure, and body temperature during surgical manipulations in both KLT and T groups
| Event during surgery | Heart rate (beats/min)
| Mean blood pressure (mm Hg)
| Body temperature (ºC)
| |||
|---|---|---|---|---|---|---|
| KLT | T | KLT | T | KLT | T | |
| Skin prep (baseline) | 92 (80–112) | 96 (80–120) | 58 (46–72) | 62 (55–94) | 37.5 (36.2–37.6) | 37.4 (36.7–38.3) |
| Skin incision | 102 (73–119) | 107 (84–110) | 62 (52–68) | 79 (66–108) | 37.3 (36.4–37.5) | 37.1 (36.6–38.0) |
| First pedicle | 106 (80–115) | 121 (112–130) | 95 (66–110) | 112 (79–116) | 37.1 (36.7–37.3) | 36.8 (36.2–37.6) |
| Second pedicle | 117 (84–140) | 120 (109–136) | 99 (64–122) | 111 (72–116) | 36.9 (36.4–37.3) | 36.6 (36.0–37.6) |
| Uterine body | 119 (84–131) | 116 (99–140) | 90 (63–120) | 109 (78–117) | 36.8 (36.4–37.2) | 36.6 (35.8–37.6) |
| Linea alba | 117 (84–137) | 119 (90–180) | 63 (58–94) | 102 (76–117) | 36.7 (35.9–37.2) | 36.5 (35.7–37.5) |
| Subcutaneous | 113 (80–122) | 113 (93–130) | 63 (55–92) | 103 (71–121) | 36.6 (35.6–37.2) | 36.4 (35.5–37.5) |
| Skin closure | 113 (80–120) | 113 (98–129) | 60 (52–92) | 100 (72–117) | 36.5 (35.5–37.2) | 36.3 (35.5–37.4) |
Notes:
Significantly different from KLT at corresponding time points (Mann–Whitney U test P<0.05).
Significantly different from values at skin preparation within group (Wilcoxon signed-rank test P<0.05).
Abbreviations: KLT, ketamine, lidocaine, and tramadol; T, tramadol.
Median score (range) for Glasgow composite pain score
| Time (hours) | KLT | T |
|---|---|---|
| 0 | 0 (0–0) | 0 (0–0) |
| 1 | 1 (1–3) | 1 (1–5) |
| 2 | 1 (1–3) | 2 (1–3) |
| 4 | 1 (0–1) | 1 (1–2) |
| 6 | 1 (0–2) | 1 (0–2) |
| 8 | 1 (0–2) | 1 (0–2) |
| 12 | 1 (0–2) | 1 (0–1) |
| 18 | 0 (0–2) | 0 (0–1) |
| 24 | 0 (0–1) | 0 (0–1) |
| 30 | 0 (0–0) | 0 (0–0) |
| 36 | 0 (0–0) | 0 (0–0) |
| 42 | 0 (0–0) | 0 (0–0) |
| 48 | 0 (0–0) | 0 (0–0) |
| 60 | 0 (0–0) | 0 (0–0) |
| 72 | 0 (0–0) | 0 (0–0) |
Notes: No significant difference between treatments (Mann–Whitney U test P<0.05).
Within group, significantly different from values at 0 hour (Wilcoxon Signed Rank test P<0.05).
Abbreviations: KLT, ketamine, lidocaine, and tramadol; T, tramadol.
Median values (range) for postoperative mechanical thresholds (Newton) at the abdomen, distal tibia, and distal radius of dogs treated with KLT and T
| Time point (hour) | Abdomen
| Distal tibia
| Distal radius
| |||
|---|---|---|---|---|---|---|
| KLT | T | KLT | T | KLT | T | |
| Baseline | 5.0 (3.5–5.9) | 4.4 (4.3–5.0) | 8.0 (6.6–16.0) | 8.0 (6.9–8.4) | 8.0 (6.4–12.2) | 7.4 (6.4–10.5) |
| 1 | 3.2 (0.7–13.9) | 1.9 (1.1–3.7) | 11.7 (7.8–18.0) | 11.5 (7.5–16.7) | 13.3 (8.7–18.0) | 11.2 (10.1–18.0) |
| 2 | 2.4 (0.6–11.1) | 1.5 (1.2–2.7) | 8.5 (5.3–18.0) | 10.8 (5.3–17.3) | 12.9 (7.8–18.0) | 11.6 (7.0–18.0) |
| 4 | 2.2 (0.8–7.9) | 1.5 (0.7–2.5) | 8.8 (7.3–16.5) | 11.0 (5.0–15.5) | 9.5 (7.5–18.0) | 11.0 (7.3–14.0) |
| 6 | 1.9 (1.0–8.0) | 1.4 (1.1–2.9) | 9.2 (5.5–15.0) | 7.7 (6.7–15.0) | 10.6 (7.1–13.3) | 9.0 (6.4–13.3) |
| 8 | 2.0 (1.6–6.7) | 1.3 (1.0–2.0) | 8.9 (5.5–18.0) | 8.9 (5.8–9.6) | 9.9 (5.3–17.8) | 8.1 (6.1–12.3) |
| 12 | 1.9 (0.8–3.8) | 1.0 (0.8–1.5) | 8.0 (6.0–16.3) | 7.1 (5.2–9.0) | 8.6 (6.7–16.0) | 7.0 (6.0–8.1) |
| 18 | 1.8 (0.6–2.4) | 1.0 (0.8–1.5) | 6.9 (5.8–11.2) | 6.7 (4.6–9.6) | 8.1 (6.3–12.1) | 6.4 (5.6–9.2) |
| 24 | 2.1 (0.8–2.5) | 1.1 (0.9–1.7) | 6.7 (4.4–7.4) | 6.4 (4.8–9.3) | 8.6 (5.4–9.6) | 6.4 (5.4–7.2) |
| 30 | 1.6 (0.5–2.9) | 0.9 (0.7–1.4) | 7.4 (5.0–9.4) | 5.6 (3.8–8.0) | 7.3 (5.8–9.5) | 5.8 (4.4–7.5) |
| 36 | 2.0 (0.2–3.1) | 1.0 (0.7–1.7) | 6.7 (4.9–7.5) | 5.4 (3.5–6.6) | 7.5 (6.2–9.5) | 5.7 (5.5–7.2) |
| 42 | 2.1 (0.2–3.2) | 1.1 (0.6–1.8) | 6.2 (5.9–7.2) | 5.8 (3.8–6.5) | 7.8 (6.3–9.3) | 6.2 (4.9–7.3) |
| 48 | 1.9 (0.2–3.2) | 1.3 (0.7–2.8) | 7.1 (5.2–7.6) | 5.7 (4.4–7.9) | 6.9 (6.9–8.2) | 6.1 (5.5–7.4) |
| 60 | 1.9 (0.5–3.1) | 1.0 (0.7–3.8) | 6.6 (5.3–9.1) | 5.4 (3.6–7.6) | 7.0 (5.4–9.4) | 6.4 (5.6–7.2) |
| 72 | 2.1 (0.5–6.8) | 1.1 (0.7–4.4) | 7.0 (5.4–7.8) | 6.0 (4.2–8.6) | 7.7 (6.6–9.4) | 6.7 (4.6–7.3) |
Notes:
Significantly different from KLT at corresponding time point (Mann–Whitney U test P<0.05).
Significantly different from baseline values within group (Wilcoxon signed-rank test P<0.05).
Abbreviations: KLT, ketamine, lidocaine, and tramadol; T, tramadol.